Ophthotech Corp (OPHT) Expected to Announce Earnings of -$0.36 Per Share

Share on StockTwits

Brokerages forecast that Ophthotech Corp (NASDAQ:OPHT) will report earnings per share (EPS) of ($0.36) for the current quarter, Zacks reports. Zero analysts have issued estimates for Ophthotech’s earnings. Ophthotech also posted earnings per share of ($0.36) in the same quarter last year. The company is expected to issue its next quarterly earnings results on Wednesday, May 8th.

According to Zacks, analysts expect that Ophthotech will report full year earnings of ($1.21) per share for the current financial year, with EPS estimates ranging from ($1.26) to ($1.16). For the next fiscal year, analysts forecast that the company will post earnings of ($1.43) per share. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover Ophthotech.

OPHT has been the topic of a number of recent analyst reports. Zacks Investment Research lowered shares of Ophthotech from a “hold” rating to a “sell” rating in a research note on Thursday, November 22nd. ValuEngine lowered shares of Ophthotech from a “hold” rating to a “sell” rating in a research note on Wednesday, December 12th.

Shares of OPHT traded down $0.03 during mid-day trading on Friday, hitting $1.52. The company’s stock had a trading volume of 398 shares, compared to its average volume of 306,797. Ophthotech has a 52-week low of $1.02 and a 52-week high of $4.50. The stock has a market capitalization of $63.79 million, a PE ratio of -0.93 and a beta of 1.49.

A number of institutional investors have recently added to or reduced their stakes in the stock. Stonepine Capital Management LLC grew its holdings in shares of Ophthotech by 75.2% in the fourth quarter. Stonepine Capital Management LLC now owns 4,072,301 shares of the biopharmaceutical company’s stock valued at $4,887,000 after purchasing an additional 1,747,519 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Ophthotech by 4.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,802,833 shares of the biopharmaceutical company’s stock valued at $4,254,000 after acquiring an additional 83,837 shares during the period. Vanguard Group Inc increased its holdings in shares of Ophthotech by 4.9% in the 3rd quarter. Vanguard Group Inc now owns 1,802,833 shares of the biopharmaceutical company’s stock valued at $4,254,000 after acquiring an additional 83,837 shares during the period. Acadian Asset Management LLC increased its holdings in shares of Ophthotech by 4.5% in the 3rd quarter. Acadian Asset Management LLC now owns 1,216,555 shares of the biopharmaceutical company’s stock valued at $2,872,000 after acquiring an additional 52,287 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Ophthotech by 10.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 958,137 shares of the biopharmaceutical company’s stock valued at $2,261,000 after buying an additional 91,041 shares during the period. Hedge funds and other institutional investors own 45.59% of the company’s stock.

Ophthotech Company Profile

Ophthotech Corporation, a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company is developing Zimura, an inhibitor of complement factor C5, for dry and wet forms of age-related macular degeneration, a disorder of the central portion of the retina known as the macula.

Read More: Leveraged Buyout (LBO) Explained

Get a free copy of the Zacks research report on Ophthotech (OPHT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ophthotech (NASDAQ:OPHT)

Receive News & Ratings for Ophthotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ophthotech and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: Brokerages Anticipate Ross Stores, Inc.  to Announce $1.11 Earnings Per Share
Zacks: Brokerages Anticipate Ross Stores, Inc. to Announce $1.11 Earnings Per Share
Alibaba Group Holding Ltd  Holdings Trimmed by Stifel Financial Corp
Alibaba Group Holding Ltd Holdings Trimmed by Stifel Financial Corp
Dycom Industries, Inc.  Expected to Announce Earnings of $0.43 Per Share
Dycom Industries, Inc. Expected to Announce Earnings of $0.43 Per Share
5,636 Shares in National Grid plc  Purchased by VisionPoint Advisory Group LLC
5,636 Shares in National Grid plc Purchased by VisionPoint Advisory Group LLC
Ophthotech Corp  Expected to Announce Earnings of -$0.36 Per Share
Ophthotech Corp Expected to Announce Earnings of -$0.36 Per Share
4,222 Shares in Hartford Financial Services Group Inc  Purchased by Kinneret Advisory LLC
4,222 Shares in Hartford Financial Services Group Inc Purchased by Kinneret Advisory LLC


Leave a Reply

© 2006-2019 Ticker Report